Danaher closes $9.9B Masimo buyout
CEO Rainer Blair said Danaher has the money and “leadership bandwidth” to strike further deals across any of its three business areas.
Uncategorized
Health plans say AI is pushing healthcare costs higher
Nearly 70% of surveyed health plans said providers’ use of AI documentation and coding tools was a top three trend inflating commercial healthcare costs next year, according to a new report from PwC.
Health plans say AI is pushing healthcare costs higher Read More »
Humana divests interest in end-of-life provider Gentiva valued at $900M
The insurer is offloading its interest in the massive end-of-life care provider to an undisclosed group of investors, amid widespread concern about private investors’ activity in healthcare.
Humana divests interest in end-of-life provider Gentiva valued at $900M Read More »
UHS deal exposes pitfalls of physician group acquisitions
Despite major financial struggles, some providers at a physician group in Washington, D.C. say their new — and much larger — parent is not offering the lifeline they want.
UHS deal exposes pitfalls of physician group acquisitions Read More »
Adoptar la IA en la empresa: cómo hacerlo sin caos y de forma eficiente
La inteligencia artificial ha pasado en muy poco tiempo de ser una tecnología emergente a convertirse en una herramienta cotidiana en el entorno empresarial. Desde la generación de contenidos hasta el análisis de datos, cada vez son más los equipos que incorporan IA en su …
Adoptar la IA en la empresa: cómo hacerlo sin caos y de forma eficiente Read More »
UPMC to lay off 200 employees, cut 300 open positions
A spokesperson said the layoffs were primarily in non-clinical or member facing roles.
UPMC to lay off 200 employees, cut 300 open positions Read More »
Genentech R&D layoffs hit top exec who’s been with the biotech nearly 30 years
The staffing changes will focus resources on work that creates the highest impact for patients, according to Genentech. The number of employees affected is unknown, but longtime veteran Vishva Dixit is out.
Genentech R&D layoffs hit top exec who’s been with the biotech nearly 30 years Read More »
Why Insulet thinks its fully closed loop system will stand apart from rivals
Chief Medical Officer Trang Ly said the system, which allows people to manage Type 2 diabetes without bolusing, will be “completely different” than those being developed by MiniMed and Tandem Diabetes Care.
Why Insulet thinks its fully closed loop system will stand apart from rivals Read More »
Medicare insolvency date creeps forward thanks to ‘Big Beautiful Bill,’ trustees find
The trust fund underpinning Medicare’s hospital benefit is set to run out of money one quarter earlier than previously expected as tax cuts in the GOP’s reconciliation legislation shrink Medicare’s revenue.
Medicare insolvency date creeps forward thanks to ‘Big Beautiful Bill,’ trustees find Read More »
Takeda’s AI-designed pill bests BMS’ Sotyktu in head-to-head psoriasis trial
Takeda eyes an FDA run for its investigational psoriasis pill after the drug elicited total skin clearance in more than 35% of patients at 16 weeks—more than 2.5 times that in controls taking Bristol Myers Squibb’s Sotyktu.
Takeda’s AI-designed pill bests BMS’ Sotyktu in head-to-head psoriasis trial Read More »